Deep Learning Methodologies Applied to Digital Pathology in Prostate Cancer: A Systematic Review

Abstract

Deep learning (DL), often called artificial intelligence (AI), has been increasingly used in Pathology thanks to the use of scanners to digitize slides which allow us to visualize them on monitors and process them with AI algorithms. Many articles have focused on DL applied to prostate cancer (PCa). This systematic review explains the DL applications and their performances for PCa in digital pathology. Article research was performed using PubMed and Embase to collect relevant articles. A Risk of Bias (RoB) was assessed with an adaptation of the QUADAS-2 tool. Out of the 77 included studies, eight focused on pre-processing tasks such as quality assessment or staining normalization. Most articles (n = 53) focused on diagnosis tasks like cancer detection or Gleason grading. Fifteen articles focused on prediction tasks, such as recurrence prediction or genomic correlations. Best performances were reached for cancer detection with an Area Under the Curve (AUC) up to 0.99 with algorithms already available for routine diagnosis. A few biases outlined by the RoB analysis are often found in these articles, such as the lack of external validation. This review was registered on PROSPERO under CRD42023418661.

The Applications of Artificial Intelligence for Assessing Fall Risk: Systematic Review

“…Machine learning encompasses a set of techniques applied to data and can be done in a supervised or unsupervised manner [ 39 , 40 ]. On the other hand, deep learning is typically used to work with larger data sets compared to machine learning, and its computational cost is higher [ 41 , 42 ].…”

Using digital pathology to analyze the murine cerebrovasculature

“…22 –25 Among the advantages of digital pathology are the algorithm-driven analysis of digitized images, reducing bias and improving quantitation of various parameters. 26 –28 In addition to measurements of staining intensity and coverage, some software packages can be used to analyze microvessels via algorithms that analyze metrics of blood vessel geometry (which may track with healthy or disease states), such as blood vessel lumen area and wall thickness. 22,29,30 When using algorithm-based quantitation, it is essential to optimize the immunoreactivity’s signal-to-noise ratio, as high background staining may prevent accurate discrimination of blood vessels versus other histological features.…”